Lambert, J., Pautas, C., Terré, C., Raffoux, E., Turlure, P., Caillot, D., . . . Castaigne, S. (2019). Gemtuzumab ozogamicin for de novo acute myeloid leukemia: Final efficacy and safety updates from the open-label, phase III ALFA-0701 trial. Haematologica.
Style de citation ChicagoLambert, Juliette, et al. "Gemtuzumab Ozogamicin for De Novo Acute Myeloid Leukemia: Final Efficacy and Safety Updates From the Open-label, Phase III ALFA-0701 Trial." Haematologica 2019.
Style de citation MLALambert, Juliette, et al. "Gemtuzumab Ozogamicin for De Novo Acute Myeloid Leukemia: Final Efficacy and Safety Updates From the Open-label, Phase III ALFA-0701 Trial." Haematologica 2019.
Attention : ces citations peuvent ne pas être correctes à 100%.